1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
19.20 -0.26 (-1.34%)
315.8K
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Keros Therapeutics Inc - KROS - stock price prediction, stock price target, analyst ratings from 10 analysts

Keros Therapeutics Inc has a share price target of US$ 24, revenue growth forecast of 6831.8%, and profit growth estimate of 143.7% for FY25, based on top 10 analyst calls.